Abstract
Gulf War Syndrome (GWS), also known as Gulf War Illness (GWI), is a long-term multi-symptom disorder which was described in military veterans and civilian workers who were employed in the first Gulf War (1990-1991). During the war, personnel were exposed to a wide variety of known and potential health hazards.
The results of this current study indicate that inflammation is a component of the pathobiology of GWS. Analysis of the data resulted in a model utilizing three readily measurable biomarkers that appears to significantly augment the symptom-based case definition of GWS.
These new observations are highly relevant to the diagnosis of GWS, and to therapeutic trials. The method now needs validation in larger groups of patiens.